$400M Pfizer Class Action Settlement On Track For Approval
By Pete Brush ( February 26, 2015, 5:18 PM EST) -- A proposed $400 million deal to resolve a class action lawsuit accusing Pfizer Inc. of misleading investors about illegal off-label drug marketing was put on track for approval on Thursday, but not before a Manhattan federal judge asked pointed questions about the value of the deal and demanded a fresh round of opt-out notices for investors. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.